Can clinical pharmacists bridge a gap between medical oncologists and patients in resource-limited oncology settings? An experience in Nepal

Abstract

The clinical pharmacist's part is emerging as a key extension to the human services care team bringing about enhanced patient care in the world. The main objective of this article is to highlight the role of clinical pharmacist in an oncology setting of Nepal. An enrollment of clinical pharmacist in an oncology hospital or in oncology settings can work as a bridge between medical oncologist and patients.

Keywords

Cancer clinical pharmacist Nepal pharmacy practice

Get full access to this article

View all access options for this article.

References

Kim

. Noncommunicable diseases: current status of major modifiable risk factors in Korea. J Prev Med Public Health 2013; 46: 165–165.

Alwan A. Global status report on noncommunicable diseases 2010. World Health Organization, 2011.

Fitzmaurice

Dicker

Pain

et al.

Global burden of disease cancer collaboration the global burden of cancer 2013. JAMA Oncol 2015; 1: 505–527.

Subedi

Sharma

. Cancer treatment in Nepal: a historical background, development of treatment facilities, epidemiology and challenges for prevention and control of cancer. Austr-Asian J Canc 2012; 11: 205–212.

Pun

Pradhananga

Siwakoti

et al.

Malignant neoplasm burden in Nepal-data from the seven major cancer service hospitals for 2012. Asian Pac J Cancer Prev 2015; 16: 8659–8663.

Poudel

Huang

Neupane

. Trend of cancer incidence in Nepal from 2003 to 2012. Asian Pac J Cancer Prev 2016; 17: 2171–2175.

Poudel

Huang

Neupane

et al.

Prediction of the cancer Incidence in Nepal. Asian Pac J Cancer Prev 2017; 18: 165–168.

. Informing patients about drug effects using positive suggestion. J Manag Care Pharm 2008; 14: 395–396.

Wang

. Impact of clinical pharmacy services on KAP and QOL in cancer patients: a single-center experience. BioMed Res Int 2015; 2015: 1–8.

10.

Khanal

Poudel

Sharan

et al.

Oncology pharmacy practice in a teaching hospital in Nepal. J Oncol Pharm Prac 2010; 16: 75–79.

11.

Shrestha

Shakya

et al.

Adverse drug reaction due to cancer chemotherapy and its financial burden in different hospitals of Nepal. Int J Pharmacovigil 2017; 2: 1–7.

12.

Kaboli

Hoth

McClimon

et al.

Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006; 166: 955–964.

13.

Al-Quteimat

Al-Badaineh

. Role of oncology clinical pharmacist: a case of life-saving interventions. Int J Basic Clin Pharmacol 2017; 2: 655–658.

14.

Yamada

Nabeshima

. Pharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectives. J Pharm Health Care Sci 2015; 1: 2–2.

15.

Genord

Frost

Eid

. Opioid exit plan: a pharmacist's role in managing acute postoperative pain. J Am Pharm Assoc 2017; 57: S92–S98.

16.

Viktil

Blix

. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol 2008; 102: 275–280.

17.

Government of Nepal – Ministry of Health and Population, Hospital pharmacy directives. Kathmandu, 2015.

18.

Ranjit

. Pharmacy practice in Nepal. Can J Hosp Pharm 2016; 69: 493–493.